Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Citius Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 76 | 2 | 60 | −14 |
| Shares | 24.1M | 27.2K | 15.2M | −8.95M (−37.1%) |
| Value | $43.2M | $49.0K | $14.0M | −$29.2M (−67.7%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 1,740,220 | $1.60M | 0.00% |
| Ergoteles LLC | 451,890 | $416.0K | 0.01% |
| Qube Research & Technologies Ltd | 121,281 | $112.0K | 0.00% |
| Virtu Financial LLC | 81,410 | $75.0K | 0.01% |
| Laurion Capital Management LP | 60,295 | $55.0K | 0.00% |
| LMR Partners LLP | 58,924 | $54.0K | 0.00% |
| Two Sigma Investments, LP | 55,654 | $51.0K | 0.00% |
| Boothbay Fund Management, LLC | 39,267 | $36.0K | 0.00% |
| AQR Capital Management LLC | 25,270 | $23.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16.0K | 0.00% |
| Csenge Advisory Group | 15,000 | $14.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 11,513 | $11.0K | 0.00% |
| Financial Synergies Wealth Advisors, Inc. | 200 | $184 | 0.00% |
| Rockefeller Capital Management L.P. | 50 | $0 | 0.00% |
| Aspire Private Capital, LLC | 300 | $0 | 0.00% |
Sold out (29)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 13,731 | $25.0K |
| Parametric Portfolio Associates LLC | 13,477 | $24.0K |